| Company Name: |
Quality Control Solutions Ltd.
|
| Tel: |
0755-66853366 13670046396 |
| Email: |
orders@qcsrm.com |
| Products Intro: |
Product Name:Ticagrelor Impurity 66
CAS:1643378-48-6
Purity:95% HPLC Package:10mg;25mg;50mg;100mg
|
| Company Name: |
Hubei Yangxin Medical Technology Co., Ltd.
|
| Tel: |
15374522761 |
| Email: |
3003392093@yongstandards.com |
| Products Intro: |
Product Name:Ticagrelor Impurity 177
CAS:1643378-48-6
Purity:99%+ HPLC Package:10mg;25mg;50mg;100mg
|
|
| | Ticagrelor Impurity 15 Basic information |
| Product Name: | Ticagrelor Impurity 15 | | Synonyms: | Ticagrelor Impurity 177;Ticagrelor Difluoro Impurity/(1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(2,3-Difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-1,2-cyclopentanediol;(1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(2,3-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol;Ticagrelor impurity 2/Ticagrelor Difluoro Impurity/(1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(2,3-Difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-1,2-cyclopentanediol;Ticagrelor Impurity 132;Ticagrelor 2,3-Difluoro Isomer;1,2-Cyclopentanediol, 3-[7-[[(1R,2S)-2-(2,3-difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-, (1S,2S,3R,5S)-;"2,3-Difluoro Ticagrelor" | | CAS: | 1643378-48-6 | | MF: | C23H28F2N6O4S | | MW: | 522.57 | | EINECS: | | | Product Categories: | | | Mol File: | 1643378-48-6.mol |  |
| | Ticagrelor Impurity 15 Chemical Properties |
| Boiling point | 764.1±70.0 °C(Predicted) | | density | 1.67±0.1 g/cm3(Predicted) | | pka | 13.26±0.70(Predicted) |
| | Ticagrelor Impurity 15 Usage And Synthesis |
| Uses | (1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(2,3-difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-1,2-cyclopentanediol is an impurity of Ticagrelor (T437700) which is a anticoagulant used in the treatment of acute coronary syndromes. |
| | Ticagrelor Impurity 15 Preparation Products And Raw materials |
|